Vaxart, Inc. Comprehensive Income
Vaxart, Inc. (VXRT) reported Comprehensive Income of -$13.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- Vaxart, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$13.50M.
- Vaxart, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $5.17M.
- Vaxart, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $55.04M.
- Vaxart, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$8.14M.
- Vaxart, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$82.17M.
- Vaxart, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$107.98M.
- Vaxart, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$70.54M.
- Vaxart, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$32.22M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$13.50M 10-Q · filed 2026-08-06 | -$8.32M 10-Q · filed 2026-08-06 | $46.72M derived: sum of 3 quarters · filed 2026-08-06 | $38.59M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $5.17M S-1 · filed 2026-05-08 | $60.22M derived: sum of 2 quarters · filed 2026-05-08 | $52.08M derived: sum of 3 quarters · filed 2026-05-08 | $37.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $55.04M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $46.91M derived: sum of 2 quarters · filed 2026-05-08 | $31.92M derived: sum of 3 quarters · filed 2026-08-06 | $16.32M S-1 · filed 2026-05-08 | ||||
| 2025-09-30 | -$8.14M 10-Q · filed 2025-11-13 | -$23.12M derived: sum of 2 quarters · filed 2026-08-06 | -$38.72M 10-Q · filed 2025-11-13 | -$50.73M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$14.99M 10-Q · filed 2026-08-06 | -$30.59M 10-Q · filed 2026-08-06 | -$42.60M derived: sum of 3 quarters · filed 2026-08-06 | -$56.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$15.60M S-1 · filed 2026-05-08 | -$27.61M derived: sum of 2 quarters · filed 2026-05-08 | -$41.65M derived: sum of 3 quarters · filed 2026-05-08 | -$58.12M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$12.01M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | -$26.05M derived: sum of 2 quarters · filed 2026-05-08 | -$42.52M derived: sum of 3 quarters · filed 2026-05-08 | -$66.94M S-1 · filed 2026-05-08 | ||||
| 2024-09-30 | -$14.04M 10-Q · filed 2025-11-13 | -$30.51M derived: sum of 2 quarters · filed 2025-11-13 | -$54.94M 10-Q · filed 2025-11-13 | -$72.30M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$16.47M 10-Q · filed 2025-08-13 | -$40.90M 10-Q · filed 2025-08-13 | -$58.26M derived: sum of 3 quarters · filed 2025-08-13 | -$75.65M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$24.43M 10-Q · filed 2025-05-13 | -$41.79M derived: sum of 2 quarters · filed 2025-05-13 | -$59.18M derived: sum of 3 quarters · filed 2025-05-13 | -$81.68M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$17.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$34.75M derived: sum of 2 quarters · filed 2025-03-20 | -$57.26M derived: sum of 3 quarters · filed 2025-03-20 | -$82.17M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | -$17.39M 10-Q · filed 2024-11-13 | -$39.89M derived: sum of 2 quarters · filed 2024-11-13 | -$64.80M 10-Q · filed 2024-11-13 | -$88.50M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$22.50M 10-Q · filed 2024-08-08 | -$47.41M 10-Q · filed 2024-08-08 | -$71.11M derived: sum of 3 quarters · filed 2024-08-08 | -$100.53M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$24.91M 10-Q · filed 2024-05-13 | -$48.61M derived: sum of 2 quarters · filed 2024-05-13 | -$78.03M derived: sum of 3 quarters · filed 2024-05-13 | -$107.56M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$23.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$53.12M derived: sum of 2 quarters · filed 2024-03-14 | -$82.65M derived: sum of 3 quarters · filed 2024-03-14 | -$107.98M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$29.42M 10-Q · filed 2023-11-02 | -$58.95M derived: sum of 2 quarters · filed 2023-11-02 | -$84.28M 10-Q · filed 2023-11-02 | -$105.12M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$29.53M 10-Q · filed 2023-08-03 | -$54.87M 10-Q · filed 2023-08-03 | -$75.70M derived: sum of 3 quarters · filed 2023-08-03 | -$93.28M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$25.34M 10-Q · filed 2023-05-04 | -$46.17M derived: sum of 2 quarters · filed 2023-05-04 | -$63.75M derived: sum of 3 quarters · filed 2023-05-04 | -$79.87M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$20.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$38.41M derived: sum of 2 quarters · filed 2023-03-15 | -$54.53M derived: sum of 3 quarters · filed 2023-03-15 | -$70.54M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$17.58M 10-Q · filed 2022-11-09 | -$33.70M derived: sum of 2 quarters · filed 2022-11-09 | -$49.71M 10-Q · filed 2022-11-09 | -$63.57M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$16.12M 10-Q · filed 2022-08-08 | -$32.13M 10-Q · filed 2022-08-08 | -$45.99M derived: sum of 3 quarters · filed 2022-08-08 | -$54.08M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | -$16.01M 10-Q · filed 2022-05-09 | -$29.87M derived: sum of 2 quarters · filed 2022-05-09 | -$37.96M derived: sum of 3 quarters · filed 2022-05-09 | -$46.94M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | -$13.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$21.95M derived: sum of 2 quarters · filed 2022-02-24 | -$30.92M derived: sum of 3 quarters · filed 2022-02-24 | -$32.22M 10-K · filed 2022-02-24 | ||||
| 2020-09-30 | -$8.09M 10-Q · filed 2021-11-04 | -$17.06M derived: sum of 2 quarters · filed 2021-11-04 | -$18.36M 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | -$8.98M 10-Q · filed 2021-08-05 | -$10.27M 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | -$1.30M 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | -$18.64M 10-K · filed 2022-02-24 | |||||||
| 2017-06-30 | -$29.40M 10-K · filed 2017-09-01 | |||||||
| 2016-06-30 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | -$12.10M derived: sum of 2 quarters · filed 2017-09-01 | -$18.60M derived: sum of 3 quarters · filed 2017-09-01 | -$25.30M 10-K · filed 2017-09-01 | ||||
| 2016-03-31 | -$5.20M 10-Q · filed 2016-05-10 | -$11.70M derived: sum of 2 quarters · filed 2016-05-10 | -$18.40M 10-Q · filed 2016-05-10 | -$38.30M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2015-12-31 | -$6.50M 10-Q · filed 2016-02-08 | -$13.20M 10-Q · filed 2016-02-08 | -$33.10M derived: sum of 3 quarters · filed 2016-09-13 | -$34.60M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2015-09-30 | -$6.60M 10-Q · filed 2015-11-06 | -$26.60M derived: sum of 2 quarters · filed 2016-09-13 | -$28.10M derived: sum of 3 quarters · filed 2016-09-13 | -$24.20M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2015-06-30 | -$20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -$21.50M derived: sum of 2 quarters · filed 2016-09-13 | -$17.60M derived: sum of 3 quarters · filed 2016-09-13 | -$27.00M 10-K · filed 2016-09-13 | ||||
| 2015-03-31 | -$1.50M 10-Q · filed 2016-05-10 | $2.40M derived: sum of 2 quarters · filed 2016-05-10 | -$7.00M 10-Q · filed 2016-05-10 | -$16.30M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-12-31 | $3.90M 10-Q · filed 2016-02-08 | -$5.50M 10-Q · filed 2016-02-08 | -$14.80M derived: sum of 3 quarters · filed 2016-09-13 | -$10.30M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-09-30 | -$9.40M 10-Q · filed 2015-11-06 | -$18.70M derived: sum of 2 quarters · filed 2016-09-13 | -$14.20M derived: sum of 3 quarters · filed 2016-09-13 | -$15.30M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-06-30 | -$9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -$4.80M derived: sum of 2 quarters · filed 2016-09-13 | -$5.90M derived: sum of 3 quarters · filed 2016-09-13 | -$9.50M 10-K · filed 2016-09-13 | ||||
| 2014-03-31 | $4.50M 10-Q · filed 2015-05-08 | $3.40M derived: sum of 2 quarters · filed 2015-05-08 | -$200.00K 10-Q · filed 2015-05-08 | -$12.40M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-12-31 | -$1.10M 10-Q · filed 2015-02-06 | -$4.70M 10-Q · filed 2015-02-06 | -$16.90M derived: sum of 3 quarters · filed 2015-09-11 | -$16.20M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-09-30 | -$3.60M 10-Q · filed 2014-11-07 | -$15.80M derived: sum of 2 quarters · filed 2015-09-11 | -$15.10M derived: sum of 3 quarters · filed 2015-09-11 | -$10.80M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-06-30 | -$12.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | -$11.50M derived: sum of 2 quarters · filed 2015-09-11 | -$7.20M derived: sum of 3 quarters · filed 2015-09-11 | -$13.10M 10-K · filed 2015-09-11 | -$12.90M 10-K · filed 2013-09-27 | |||
| 2013-03-31 | $700.00K 10-Q · filed 2014-05-12 | $751.00K 10-Q · filed 2013-05-10 | $5.00M derived: sum of 2 quarters · filed 2014-05-12 | -$900.00K 10-Q · filed 2014-05-12 | -$661.00K 10-Q · filed 2013-05-10 | -$8.36M derived: sum of 4 quarters · filed 2014-09-30 | ||
| 2012-12-31 | $4.30M 10-Q · filed 2014-02-10 | $4.54M 10-Q · filed 2013-02-11 | -$1.60M 10-Q · filed 2014-02-10 | -$1.41M 10-Q · filed 2013-02-11 | -$9.05M derived: sum of 3 quarters · filed 2014-09-30 | -$9.48M derived: sum of 4 quarters · filed 2014-09-30 | ||
| 2012-09-30 | -$5.90M 10-Q · filed 2013-11-12 | -$13.36M derived: sum of 2 quarters · filed 2014-09-30 | -$13.78M derived: sum of 3 quarters · filed 2014-09-30 | -$17.83M derived: sum of 4 quarters · filed 2014-09-30 | ||||
| 2012-06-30 | -$7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | -$7.88M derived: sum of 2 quarters · filed 2014-09-30 | -$11.93M derived: sum of 3 quarters · filed 2014-09-30 | -$22.20M 10-K · filed 2014-09-30 | ||||
| 2012-03-31 | -$427.00K 10-Q · filed 2013-05-10 | -$4.48M derived: sum of 2 quarters · filed 2013-05-10 | -$14.74M 10-Q · filed 2013-05-10 | |||||
| 2011-12-31 | -$4.05M 10-Q · filed 2013-02-11 | -$14.32M 10-Q · filed 2013-02-11 | ||||||
| 2011-06-30 | -$6.60M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |